Pembrolizumab in HER2-Positive Gastric Cancer

被引：19

作者：

Janjigian, Yelena Y. ^{[1
]}

Kawazoe, Akihito ^{[2
]}

Bai, Yuxian ^{[3
]}

Xu, Jianming ^{[4
]}

Lonardi, Sara ^{[5
]}

Metges, Jean Phillipe ^{[6
]}

Yanez, Patricio ^{[7
]}

Wyrwicz, Lucjan S. ^{[8
]}

Shen, Lin ^{[9
]}

Ostapenko, Yuriy ^{[10
]}

Bilici, Mehmet ^{[11
]}

Chung, Hyun Cheol ^{[12
]}

Shitara, Kohei

Qin, Shukui ^{[13
]}

Van Cutsem, Eric ^{[14
]}

Tabernero, Josep ^{[15
]}

Luo, Suxia ^{[16
]}

Mahave, Mauricio ^{[17
]}

Tang, Yong ^{[18
]}

Lowery, Maeve ^{[19
]}

Monteiro, Maria M. F. ^{[20
]}

Xu, Linzhi ^{[21
]}

Shih, Chie-Schin ^{[21
]}

Sharan, Kanu P. ^{[21
]}

Bhagia, Pooja ^{[21
]}

Rha, Sun Young ^{[12
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10029 USA

[2] Natl Canc Hosp East, Kashiwa, Japan

[3] Harbin Med Univ Canc Hosp, Harbin, Peoples R China

[4] Fifth Med Ctr Peoples Liberat Army, Beijing, Peoples R China

[5] Ist Oncol Veneto, Padua, Italy

[6] Univ Hosp Brest, Brest, France

[7] James Lind Canc Res Ctr, Temuco, Chile

[8] Maria Sklodowska Curie Natl Canc Res Inst, Warsaw, Poland

[9] Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China

[10] Natl Canc Inst, Kiev, Ukraine

[11] Ataturk Univ, Erzurum, Turkiye

[12] Yonsei Canc Ctr, Seoul, South Korea

[13] Canc Ctr Peoples Liberat Army, Nanjing, Peoples R China

[14] Univ Hosp Gasthuisberg, Leuven, Belgium

[15] Vall dHebron Univ Hosp, Inst Oncol, Barcelona, Spain

[16] Henan Canc Hosp, Zhengzhou, Peoples R China

[17] Fdn Arturo Lopez Perez, Santiago, Chile

[18] Xinjiang Med Univ, Canc Hosp, Urumqi, Peoples R China

[19] Trinity St Jamess Canc Inst, Dublin, Ireland

[20] Inst Canc Ceara, Fortaleza, CE, Brazil

[21] Merck, Rahway, NJ USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2024年

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1056/NEJMc2408121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pembrolizumab in HER2-Positive Gastric Cancer The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.

引用

页数：3

共 50 条

[31] Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer [J].

Kotani, Daisuke ;

Shitara, Kohei .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13

[32] SECOND-LINE TREATMENT OF HER2-POSITIVE GASTRIC CANCER [J].

Hamamoto, Y. ;

Funakoshi, S. ;

Higuchi, H. ;

Takaishi, H. ;

Hibi, T. .

ANNALS OF ONCOLOGY, 2012, 23 :76-76

[33] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer [J].

Mueller, Volkmar ;

Clemens, Michael ;

Jassem, Jacek ;

Al-Sakaff, Nedal ;

Auclair, Petra ;

Nuesch, Eveline ;

Holloway, Debbie ;

Shing, Mona ;

Bang, Yung-Jue .

BMC CANCER, 2018, 18

[34] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer [J].

Volkmar Müller ;

Michael Clemens ;

Jacek Jassem ;

Nedal Al-Sakaff ;

Petra Auclair ;

Eveline Nüesch ;

Debbie Holloway ;

Mona Shing ;

Yung-Jue Bang .

BMC Cancer, 18

[35] HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer [J].

Lordick, F. ;

Bang, Y. J. ;

Kang, Y. K. ;

Otero Reyes, D. ;

Manikhas, G. M. ;

Shen, L. ;

Kulikov, E. ;

Stoss, O. ;

Jordan, B. W. M. ;

Van Cutsem, E. .

EJC SUPPLEMENTS, 2007, 5 (04) :272-272

[36] HER2-positive breast cancer [J].

Loibl, Sibylle ;

Gianni, Luca .

LANCET, 2017, 389 (10087) :2415-2429

[37] Pembrolizumab for HER2+ gastric cancer [J].

David Killock .

Nature Reviews Clinical Oncology, 2022, 19 :150-150

[38] Pembrolizumab for HER2+ gastric cancer [J].

Killock, David .

NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (03) :150-150

[39] Cerebrospinal Fluid Cytology Diagnosis of HER2-Positive Leptomeningeal Carcinomatosis From HER2-Positive Metastatic Gastric Cancer: Case Report [J].

Cavanna, Luigi ;

Rocchi, Andrea ;

Gorgni, Silvia ;

Ambroggi, Massimo ;

Foroni, Raoul P. ;

Ubbiali, Alessandro ;

Civardi, Giuseppe .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) :E367-E368

[40] NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer [J].

Holden, Joanne ;

Garrett, Zoe ;

Stevens, Andrew .

LANCET ONCOLOGY, 2011, 12 (01) :16-17

← 1 2 3 4 5 →